Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep;69(9):e29620.
doi: 10.1002/pbc.29620. Epub 2022 Feb 21.

Comment on: Repeat-positive SARS-CoV-2 in a child with cancer: Intermittent positive results of SARS-CoV-2-RNA in nasopharyngeal swabs during chemotherapy in a child with acute leukemia

Sırma Karamercan  1 , Zühre Kaya  1 , Ülker Koçak  1
Affiliations
Comment

Comment on: Repeat-positive SARS-CoV-2 in a child with cancer: Intermittent positive results of SARS-CoV-2-RNA in nasopharyngeal swabs during chemotherapy in a child with acute leukemia

Sırma Karamercan et al. Pediatr Blood Cancer. 2022 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Changes in leukocyte, neutrophil and lymphocyte counts, and positive results of SARS‐CoV‐2‐RNA in a child with leukemia during ALL‐BFM protocol
See this image and copyright information in PMC

Comment on

  • Repeat-positive SARS-CoV-2 in a child with cancer.
    Radhakrishnan V, Gangopadhyay D. Radhakrishnan V, et al. Pediatr Blood Cancer. 2021 Mar;68(3):e28744. doi: 10.1002/pbc.28744. Epub 2020 Oct 3. Pediatr Blood Cancer. 2021. PMID: 33009874 Free PMC article. No abstract available.

References

    1. Radhakrishnan V, Gangopadhyay D. Repeat‐positive SARS‐CoV‐2 in a child with cancer. Pediatr Blood Cancer. 2021;68(3):e28744. - PMC - PubMed
    1. Goubet AG, Dubuisson A, Geraud A, et al. Prolonged SARS‐CoV‐2 RNA virus shedding and lymphopenia are hallmarks of COVID‐19 in cancer patients with poor prognosis. Cell Death Differ. 2021;28(12):3297‐3315. - PMC - PubMed
    1. Shahid S, Jabbar N, Mansoor N, Rafiq N, Maqsood S. Comparison of clinical and diagnostic features of pediatric oncology patients with or without COVID‐19 infection: a retrospective chart review. J Pediatr Hematol Oncol. 2021. 10.1097/MPH.0000000000002303 - DOI - PubMed
    1. Pani A, Lauriola M, Romandini A, Scaglione F. Macrolides and viral infections: focus on azithromycin in COVID‐19 pathology. Int J Antimicrob Agents. 2020;56(2):106053. - PMC - PubMed
    1. Echeverría‐Esnal D, Martin‐Ontiyuelo C, Navarrete‐Rouco ME, et al. Azithromycin in the treatment of COVID‐19: a review. Expert Rev Anti Infect Ther. 2021;19(2):147‐163. - PubMed